Companies
Science we believe in.
Companies we’ve built.
Automera is focused on the development of a novel therapeutic approach via autophagy-based targeted protein degradation.Read more
Bisirna is a clinical-stage biotech company developing RNAi therapies for major diseases.Read more
Biobot Surgical Pte. Ltd. is a global leader in robotic precision for prostate disease management.Read more
Callio Therapeutics is a clinicalstage biotech company engineering dual-payload antibody-drug conjugates (ADCs) for the next frontier of targeted cancer therapy.Read more
Cirrus Therapeutics is an ocular immunology-focused biotech company developing cell and gene therapies for age-related macular degeneration (AMD) and other chronic blinding diseases to preserve sight, extend ocular healthspan, and enable a better quality of life as people age.Read more
Engine Biosciences discovers and develops precision oncology medicines through the application of functional genomics, machine learning, computational chemistry, and cancer cell biology.Read more
Eyexora is a global ophthalmology company pioneering a hub-and-spoke model to accelerate innovation in eye care. By centralizing scientific, clinical, regulatory, and commercial expertise, Eyexora advances a pipeline of therapies through focused subsidiaries, to reduce risk, improve efficiency, and scale impact.Read more
Hummingbird Bioscience is a clinical stage biotech company integrating AI and systems biology to discover and develop breakthrough medicines for cancer and autoimmune diseases.Read more
IASO Biotechnology is a commercial stage biopharmaceutical company focusing on cell therapies and biologics targeting hematologic malignancies and autoimmune diseases, with a full-process platform covering drug discovery, development, manufacturing, and commercialization.Read more
Leyden Labs is a clinical-stage biotech company leveraging its Mucosal Protection Platform to develop a portfolio of candidates aimed at providing protection against respiratory viruses through a new class of broadly protective nasal sprays.Read more
Nuevocor is a clinical-stage biotech company developing novel therapies for genetic cardiomyopathies driven by aberrant mechanobiology. Its unique mechanobiology approach surpasses the limitations of traditional gene replacement therapy – which treats individual gene mutations – to treating functional defects in shared disease pathways across multiple cardiomyopathies.Read more
Paratus Sciences is decoding evolution to discover and develop first-in-class medicines for serious diseases where today’s therapies fall short. Paratus Sciences integrates evolutionary biology, AI-powered discovery and deep multi-omic data to uncover biologically validated pathways that can inform new medicines.Read more
Quilt is a digital health company tackling the engagement gap in mental and behavioural healthcare through an automated end-to-end content generation platform. It enables healthcare providers to rapidly create clinically relevant content tailored to specific conditions - such as addiction and depression - and deliver it to the relevant patients who need it most. Patients receive personalised, condition-specific information designed to support and improve their mental health, closing the gap between provider intent and patient engagement that so often undermines behavioural health outcomes.Read more
Rejoni is a medical device company focused on developing gynecological products using its proprietary biomaterials. Its first product, the Juveena® Hydrogel System, is designed to prevent intrauterine adhesions (IUAs) following transcervical interventions.Read more
Respiree is a medtech company turning continuous vital-sign data into early warnings that change patient outcomes across acute, transitional and home-care settings. Its RS001 wearable, paired with the 1Bio connected-care platform, applies clinically validated AI algorithms to flag patient deterioration days before an exacerbation in high-burden conditions like COPD. Its products have secured regulatory clearances across multiple regions - including CE marking, Australia's TGA and US FDA 510(k) - and forged partnerships with global healthcare leaders Philips and Roche Diagnostics.Read more
Zenflow is reinventing BPH treatment for the millions of men living with an enlarged prostate. Its PMA-approved Spring System, implanted in a quick and minimally invasive procedure, delivers durable symptom relief while preserving future treatment options and streamlining physician workflow, offering a lasting treatment that spares patients the side effects of daily medication and the risks of invasive surgery.Read more
65LAB is established by global investors ClavystBio, Leaps by Bayer, Lightstone Ventures, Polaris Partners and the Polaris Innovation Fund, together with global life science company Evotec. Its mission is to translate scientific breakthroughs from Singapore's research ecosystem into new biotech ventures.Read more